Want to see SPRO full AI Analyst Report?

Spero Therapeutics (SPRO) Revenue

600 Followers

Spero Therapeutics Revenue

Spero Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2026, with -100.00%. This bring the company's revenue in the last twelve months to 42.96M, Increased -21.55%. In the fiscal year ending Dec 31, 2025, Spero Therapeutics had annual revenue of 59.62M with 24.27% growth.

Revenue (ttm)

42.96M

Revenue Growth

26.04%

P/S Ratio

1.18

Revenue/Employee

$2,384,760

Employees

Market Cap

$70.46M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	59.62M	11.64M	+24.27%
Dec 31, 2024	47.98M	-55.80M	-53.77%
Dec 31, 2023	103.78M	55.20M	+113.63%
Dec 31, 2022	48.58M	45.51M	+1,482.38%
Mar 31, 2022	3.07M	-6.26M	-67.10%
Dec 31, 2020	9.33M	-8.82M	-48.59%
Dec 31, 2019	18.15M	14.18M	+357.56%
Dec 31, 2018	3.97M	1.99M	+100.40%
Dec 31, 2017	1.98M	―	―